| ADR Ontology |
| ADR Term |
Vagus nerve disorder |
| ADR ID |
BADD_A08550 |
| ADR Hierarchy |
|
| Description |
A disorder characterized by dysfunction of the vagus nerve (tenth cranial nerve). [CTCAE] Diseases of the tenth cranial nerve, including brain stem lesions involving its nuclei (solitary, ambiguus, and dorsal motor), nerve fascicles, and intracranial and extracranial course. Clinical manifestations may include dysphagia, vocal cord weakness, and alterations of parasympathetic tone in the thorax and abdomen. [MeSH] |
| MedDRA Code |
10061403 |
| MeSH ID |
D020421
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Disorders of pneumogastric (10th) nerve | Vagus nerve disorder NOS | Vagus nerve disorder | Vagus Nerve Diseases | Vagus Nerve Disease | Vagus Neuropathy | Neuropathies, Vagus | Neuropathy, Vagus | Vagus Neuropathies | Tenth Cranial Nerve Diseases | Vagus Nerve Disorders | Vagus Nerve Disorder | Cranial Nerve X Diseases | Pneumogastric Nerve Disorders | Disorder, Pneumogastric Nerve | Disorders, Pneumogastric Nerve | Pneumogastric Nerve Disorder | Sensory Disorder, Vagus Nerve | Vagus Nerve Sensory Disorder | Motor Disorder, Vagus Nerve | Vagus Nerve Motor Disorder |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00085 | Alprazolam | 0.000029% | | | BADD_D00947 | Fluticasone propionate | - | - |
| The 1th Page 1
Total 1 Pages
|
|
